Accuracy and impact of risk assessment in the primary prevention of cardiovascular disease: a systematic review.
about
Computer-assisted versus oral-and-written history taking for the prevention of cardiovascular diseaseRisk scoring for the primary prevention of cardiovascular diseaseRisk scoring for the primary prevention of cardiovascular diseaseComputer-assisted versus oral-and-written history taking for the prevention of cardiovascular diseaseRisk scoring for the primary prevention of cardiovascular diseaseCan non-physician health-care workers assess and manage cardiovascular risk in primary care?Risk assessment in the prevention of cardiovascular disease in low-resource settingsPotential Diagnostic and Prognostic Biomarkers of Epigenetic Drift within the Cardiovascular CompartmentRisk prediction tools for cancer in primary careImpact of provision of cardiovascular disease risk estimates to healthcare professionals and patients: a systematic reviewCardiovascular riskCharacteristics of high risk people with cardiovascular disease in Chinese rural areas: clinical indictors, disease patterns and drug treatmentUse of medications and lifestyles of hypertensive patients with high risk of cardiovascular disease in rural ChinaScreening for future cardiovascular disease using age alone compared with multiple risk factors and ageEffect of using cardiovascular risk scoring in routine risk assessment in primary prevention of cardiovascular disease: protocol for an overview of systematic reviewsProtocol of the Swiss Longitudinal Cohort Study (SWICOS) in rural Switzerland.Development of a cardiovascular risk score for use in low- and middle-income countriesPredicting streptococcal pharyngitis in adults in primary care: a systematic review of the diagnostic accuracy of symptoms and signs and validation of the Centor score.Information and Risk Modification Trial (INFORM): design of a randomised controlled trial of communicating different types of information about coronary heart disease risk, alongside lifestyle advice, to achieve change in health-related behaviourIndependent associations of fasting insulin, glucose, and glycated haemoglobin with stroke and coronary heart disease in older womenWidening access to cardiovascular healthcare: community screening among ethnic minorities in inner-city Britain - the Healthy Hearts ProjectSex and ethnic differences in 47 candidate proteomic markers of cardiovascular disease: the Mayo Clinic proteomic markers of arteriosclerosis studyImpact of statins therapy on morphological changes in lipid-rich plaques stratified by 10-Year framingham risk score: A serial optical coherence tomography study.Association between chemokine CXC ligand 12 gene polymorphism (rs1746048) and coronary heart disease: A MOOSE-compliant meta-analysis.Evaluating the use of mobile phone technology to enhance cardiovascular disease screening by community health workers.Testicular cancer survivorship: research strategies and recommendations.Cardiovascular risk among Aboriginal and non-Aboriginal smoking male prisoners: inequalities compared to the wider communityAnkle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysisIs there a role for coronary artery calcium scoring for management of asymptomatic patients at risk for coronary artery disease?: Clinical risk scores are sufficient to define primary prevention treatment strategies among asymptomatic patients.Using the coronary artery calcium score to guide statin therapy: a cost-effectiveness analysisGenetic profiling using genome-wide significant coronary artery disease risk variants does not improve the prediction of subclinical atherosclerosis: the Cardiovascular Risk in Young Finns Study, the Bogalusa Heart Study and the Health 2000 Survey--Prevalence of non-calcified coronary plaque on 64-slice computed tomography in asymptomatic patients with zero and low coronary artery calcium.Independent external validation of cardiovascular disease mortality in women utilising Framingham and SCORE risk models: a mortality follow-up studyDerivation, validation, and evaluation of a new QRISK model to estimate lifetime risk of cardiovascular disease: cohort study using QResearch database.Risk scoring for the primary prevention of cardiovascular disease.Global cardiovascular risk assessment in the primary prevention of cardiovascular disease in adults: systematic review of systematic reviewsCardiovascular risk estimation: important but may be inaccurateCardiovascular risk scores do not account for the effect of treatment: a review.Updated guidelines for the management of dyslipidemia and prevention of cardiovascular disease by pharmacists.Factors associated with presence and extent of coronary calcium in those predicted to be at low risk according to Framingham risk score (from the Multi-Ethnic Study of Atherosclerosis).
P2860
Q24186294-AD18429B-D40B-4F2E-8365-01E586A19525Q24186884-213B4BAD-44FB-4631-BD97-59B2179E4345Q24198953-C2D4EB77-7C8A-450A-BECF-0B0BD3E266A4Q24203604-CD26C099-A9E0-4749-8906-AEAB875AFD30Q24242166-FC5768CC-48A6-43D9-995A-C90BFF836EF4Q24657952-4F714D4D-438C-4F1E-A361-4D6895C33FB9Q26744435-F440796F-B780-4980-954B-B21727DB3647Q26768208-2AEF96EA-0754-4CC9-B3DE-AD8B2633B7F6Q26774974-30003BE8-7B2F-40A8-87FE-5CE83BB7B0B3Q26778836-31A31BD3-7711-4CB5-BFDD-E8982C5F870DQ26825634-A56C692F-68FF-4A1A-A62A-7701FF5BE918Q28485196-44532F29-6056-4D88-BFCD-253E10CE9C20Q28546905-89F6787D-027E-41FA-AD75-85A9CC9EE43FQ28740466-C318991A-CD85-4987-81A6-CA0CCB354D8AQ29247935-814C46CB-2430-4D39-A5F7-90560208B631Q30367448-4558F715-3A3D-42A9-8B21-4CCA8E12D8A7Q30501026-F61F46A1-3A3C-40E3-9240-3D2765A7FA91Q30501859-AFDEEFEA-7809-42B1-9087-0D2D19A7149EQ30663945-8D431AA8-E5E8-4C1A-B6DB-E91BAC262601Q33296042-8E745320-8796-4E05-9BEA-F1775CC3C16AQ33307064-99533A9F-205A-48A2-929C-2D3F6B4C51C6Q33530066-BDB90A91-DA74-41EF-B7B3-16EB6BF13088Q33689064-F0CB0FC0-F95D-44C3-B6A5-9616D53399A4Q33818156-FEB5AFE2-FC51-45E9-A476-FC056AA1DA02Q33940623-BE4511B8-156F-4DC6-9402-B17F1C0AE2F8Q34039684-04242310-804C-49BE-98CB-178CD8F56B51Q34045402-554DC681-192A-4B95-94CB-69C3E3836480Q34100632-108FE21E-63FD-403D-B87A-93C0E347059EQ34133250-0338B2E1-A820-4BCF-B291-EC0D333D3964Q34143079-CE449B5E-364B-49CC-AF5D-69DB31D029CCQ34147477-590D0200-6B9B-4A19-827B-BF2678965680Q34179049-09397E53-4DCF-4C25-A447-3F26D2993DC6Q34273907-92A6C366-3746-49F1-8DDA-6038EC186AAAQ34394948-F31D2D38-6FCE-48AF-937F-72E589286175Q34553211-8AAC4AE6-615A-4D67-AC93-8F78794A8F4BQ34554085-50DD45A9-9CF7-4B63-9F8C-40691C18096EQ34683655-B7287E06-8C21-429D-874B-8AA3F02F233CQ34769415-EF225831-1353-4310-9EEF-CCE3C3CC59F2Q34961885-6EC9305B-CE0A-4F8A-AE05-BEFD0D80F9DCQ35238575-FFEBA79B-498C-4729-BB2D-75DA9E0C456F
P2860
Accuracy and impact of risk assessment in the primary prevention of cardiovascular disease: a systematic review.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Accuracy and impact of risk as ...... disease: a systematic review.
@ast
Accuracy and impact of risk as ...... disease: a systematic review.
@en
type
label
Accuracy and impact of risk as ...... disease: a systematic review.
@ast
Accuracy and impact of risk as ...... disease: a systematic review.
@en
prefLabel
Accuracy and impact of risk as ...... disease: a systematic review.
@ast
Accuracy and impact of risk as ...... disease: a systematic review.
@en
P2860
P356
P1433
P1476
Accuracy and impact of risk as ...... disease: a systematic review.
@en
P2093
P2860
P304
P356
10.1136/HRT.2006.087932
P407
P577
2006-04-18T00:00:00Z